Search research articles
Contact Us
Filters
Showing results (161-170 of 978) with videos related to
Page
of 98
Sort By:
Vaccine
|
December 15, 2000
A systematic approach to vaccine complexity using an automaton model of the cellular and humoral immune system. I. Viral characteristics and polarized responses
B Kohler, R Puzone, P E Seiden, et al.
The Laryngoscope
|
June 19, 2013
The utility of magnetic resonance imaging in the diagnostic evaluation of idiopathic olfactory loss
Peter K Hoekman, Jeffrey J Houlton, Allen M Seiden
Brain Research
|
May 29, 1989
Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys
M S Kleven, W L Woolverton, L S Seiden
Synapse (New York, N.Y.)
|
May 1, 1997
Combined phentermine/fenfluramine administration enhances depletion of serotonin from central terminal fields
R Lew, B Weisenberg, G Vosmer, et al.
Biological Psychiatry
|
May 20, 1999
Serotonergic mediation of DRL 72s behavior: receptor subtype involvement in a behavioral screen for antidepressant drugs
D C Jolly, J B Richards, L S Seiden
Journal of Veterinary Internal Medicine
|
November 25, 2017
24-Hour Kinetics of Cardiac Troponin-T Using a "High-Sensitivity" Assay in Thoroughbred Chuckwagon Racing Geldings after Race and Associated Clinical Sampling Guidelines
E Shields, I Seiden-Long, S Massie, et al.
International Immunology
|
April 1, 1995
Modelling thymic functions in a cellular automaton
D Morpurgo, R Serenthà, P E Seiden, et al.
Brain Research
|
November 6, 1992
The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine
G M Farfel, G L Vosmer, L S Seiden
Brain Research
|
June 5, 1992
The NMDA receptor antagonist MK-801 does not protect against serotonin depletions caused by high doses of DL-fenfluramine
K E Sabol, J B Richards, L S Seiden
Current Medical Research and Opinion
|
May 24, 2007
A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia
Thomas Roth, David Seiden, Sherry Wang-Weigand, et al.
Page
of 98
Search research articles
Search
Showing results (161-170 of 978) with videos related to
Sort By:
Page
of 98
Vaccine
|
December 15, 2000
A systematic approach to vaccine complexity using an automaton model of the cellular and humoral immune system. I. Viral characteristics and polarized responses
B Kohler, R Puzone, P E Seiden, et al.
The Laryngoscope
|
June 19, 2013
The utility of magnetic resonance imaging in the diagnostic evaluation of idiopathic olfactory loss
Peter K Hoekman, Jeffrey J Houlton, Allen M Seiden
Brain Research
|
May 29, 1989
Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys
M S Kleven, W L Woolverton, L S Seiden
Synapse (New York, N.Y.)
|
May 1, 1997
Combined phentermine/fenfluramine administration enhances depletion of serotonin from central terminal fields
R Lew, B Weisenberg, G Vosmer, et al.
Biological Psychiatry
|
May 20, 1999
Serotonergic mediation of DRL 72s behavior: receptor subtype involvement in a behavioral screen for antidepressant drugs
D C Jolly, J B Richards, L S Seiden
Journal of Veterinary Internal Medicine
|
November 25, 2017
24-Hour Kinetics of Cardiac Troponin-T Using a "High-Sensitivity" Assay in Thoroughbred Chuckwagon Racing Geldings after Race and Associated Clinical Sampling Guidelines
E Shields, I Seiden-Long, S Massie, et al.
International Immunology
|
April 1, 1995
Modelling thymic functions in a cellular automaton
D Morpurgo, R Serenthà, P E Seiden, et al.
Brain Research
|
November 6, 1992
The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine
G M Farfel, G L Vosmer, L S Seiden
Brain Research
|
June 5, 1992
The NMDA receptor antagonist MK-801 does not protect against serotonin depletions caused by high doses of DL-fenfluramine
K E Sabol, J B Richards, L S Seiden
Current Medical Research and Opinion
|
May 24, 2007
A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia
Thomas Roth, David Seiden, Sherry Wang-Weigand, et al.
Page
of 98